$MASI News
Last published 6mo ago
- 6mo agoDHRMASIMasimo Shareholders Approve Acquisition by DanaherBusiness WireMasimo Corporation (NASDAQ:MASI) ("Masimo"), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced Agreement and Plan of
- 6mo agoMASIMasimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World StudyBusiness WireNICU Study Adds to the Evidence Demonstrating SET®'s Accuracy in Challenging Real-World Settings, With No Clinically Significant Differences in Performance Across Skin Pigmentation Categories or Race and Zero
- 7mo agoANIKAVNTCOOMASI+3Telix Strengthens Board with Additional Director AppointmentsGlobeNewswireMELBOURNE, Australia and INDIANAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:TLX, "Telix") today announces two additional Non-Executive Director (NED) appointments,
- 8mo agoMASIMASI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Masimo Corporation to Danaher CorporationGlobeNewswireMONSEY, N.Y., Feb. 17, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Masimo Corporation (NASDAQ:MASI) ("Masimo") for $180.00 per share in cash to
- 8mo agoDHRMASIMasimo to be Acquired by Danaher for $180.00 Per ShareBusiness WireMasimo Corporation (NASDAQ:MASI) ("Masimo"), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE:DHR) ("Danaher") will acquire
- 9mo agoMASIClairity Appoints Founder Dr. Connie Lehman as Chief Executive Officer; Joe Kiani Named Chairman of the BoardGlobeNewswireBOSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Clairity, a U.S.-based medical technology company advancing AI-powered breast cancer risk assessment, today announced that its founder, Connie Lehman, MD, PhD, has assumed the
- 11mo agoMASIMasimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable GrowthBusiness WireAnnounces Long-Range Targets Including 7% - 10% Revenue CAGR Through 2028 Highlights Clear Focus on Patient Outcomes, Technology Innovation and Commercial Execution Masimo (NASDAQ:MASI) today hosted its 2025 Investor
- 11mo agoMASIKnobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement CasePR NewswireA team from Knobbe Martens led medical device pioneer Masimo (NASDAQ: MASI) to a victory over Apple in a dispute involving Masimo's patented heart...
- 12mo agoMASIMasimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in DamagesBusiness WireMasimo (NASDAQ:MASI) today issued the following statement in response to the jury verdict announced in the U.S. District Court for the Central District of California, which confirmed the validity of Masimo Patent No.
- 12mo agoMASIClairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk PredictionBusiness WireWith backing from leading healthcare investors, Clairity accelerates its mission to predict and prevent breast cancer and expand into cardiovascular disease Clairity, Inc., an AI-driven precision health company
- 1y agoMASIMasimo Reports Third Quarter 2025 ResultsBusiness WireMasimo Corporation (NASDAQ:MASI) today announced its financial results for the third quarter ended September 27, 2025. Third Quarter 2025 Results From Continuing Operations(1): GAAP revenue of $371.5 million,
- 1y agoMASIMasimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4Business WireConference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ:MASI) will release third quarter 2025 financial results for the period ended September 27, 2025, after the market closes on Tuesday,
- 1y agoMASIMasimo to Host Investor Day on December 3, 2025Business WireMasimo (NASDAQ:MASI) today announced it will host a meeting with the analyst and investor community at 9:00am PT on Wednesday, December 3, 2025. Presentations will be led by select members of the Executive Leadership
- 1y agoMASIIn Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin TonesBusiness WireThe INSPIRE Trial Prospectively Assesses Pulse Oximeter Accuracy Using a Unique Real-world Study Design and in the Feasibility Study Showed No Clinically Significant Bias Between Patients with Light and Dark Skin Tones
- 1y agoMASIMasimo Completes Sale of Consumer Audio Business to HARMAN InternationalBusiness WireMasimo (NASDAQ:MASI) today announced it has completed the previously announced sale of its Sound United consumer audio business to HARMAN International ("HARMAN"), a wholly-owned subsidiary of Samsung Electronics Co.,
- 1y agoMASIHARMAN Completes Sound United Acquisition to Expand Premium Audio LeadershipBusiness WireStrategic integration of Sound United's award-winning audio brands strengthens HARMAN's product portfolio and propels business growth HARMAN International ("HARMAN"), a wholly-owned subsidiary of Samsung
- 1y agoMASIPHGMasimo Announces Expansion of Strategic Partnership with PhilipsBusiness WireMulti-Year Partnership Renewal with Broadened Focus Will Include Expedited Technology Adoption and Market-Based Strategic Development of Next-Generation Monitoring Solutions Masimo (NASDAQ:MASI) today announced a
- 1y agoMASIPHGPhilips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologiesGlobeNewswireSeptember 11, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, and Masimo (NASDAQ:MASI) today announced that the two companies have renewed their multi-year
- 1y agoMASIMasimo Corporation (MASI) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptEarnings Call Transcripts
- 1y agoMASIMasimo to Present in the Wells Fargo Healthcare ConferenceBusiness WireMasimo (NASDAQ:MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Thursday, Sept 4, 2025 at 1:30 p.m. Eastern time. A live webcast of the presentation will be
- 1y agoAAPLMASIApple Watch getting redesigned blood oxygen feature following legal disputeCNBCIn 2023, the International Trade Commission found that Apple's blood oxygen sensors infringed on intellectual property from Masimo.
- 1y agoMASIMasimo Corporation (MASI) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoMASIMasimo Reports Second Quarter 2025 ResultsBusiness WireMasimo Corporation (NASDAQ:MASI) today announced its financial results for the second quarter ended June 28, 2025. Second Quarter 2025 Results From Continuing Operations(1): GAAP revenue of $371 million,
- 1y agoMASIMasimo to Report Second Quarter 2025 Financial Results after Market Close on Tuesday, August 5Business WireConference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ:MASI) will release second quarter 2025 financial results for the period ended June 28, 2025, after the market closes on Tuesday,
- 1y agoMASIMasimo Corporation vs Apple Inc. - AIA Trial, Final Written DecisionUS Patent Trial and Appeal Board
- 1y agoMASIMasimo Corporation vs Apple Inc. - AIA Trial, Final Written DecisionUS Patent Trial and Appeal Board
- 1y agoMASINew Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric AnesthesiaBusiness WireEEG-Guided Anesthesia Using Masimo Technology Significantly Reduced Pediatric Anesthesia Emergence Delirium, Time to Emergence and Discharge, and Cost of Care by Minimizing Sevoflurane Exposure Masimo (NASDAQ:MASI)
- 1y agoMASIMasimo to Present in the Jefferies Global Healthcare ConferenceBusiness WireMasimo (NASDAQ:MASI) today announced that its management will participate in the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 1:25 p.m. Eastern time. A live webcast of the presentation will be
- 1y agoMASIMasimo to Present in the BofA Securities 2025 Health Care ConferenceBusiness WireMasimo (NASDAQ:MASI) today announced that its management will participate in the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025 at 4:20 p.m. Pacific time. A live webcast of the presentation will be
- 1y agoMASIMasimo to Sell Consumer Audio Business to HARMAN InternationalBusiness WireDivestiture Supports Masimo's Focus on Core Professional Healthcare Business and Delivering Market Leading Innovation Masimo Corporation (NASDAQ:MASI), a leading global medical innovator, today announced that it has
- 1y agoMASIMasimo Reports First Quarter 2025 ResultsBusiness WireMasimo Corporation (NASDAQ:MASI) today announced its financial results for the first quarter ended March 29, 2025. First Quarter 2025 Results From Continuing Operations(1): GAAP revenue of $372 million, representing
- 1y agoMASIMasimo to Report First Quarter 2025 Financial Results after Market Close on Tuesday, May 6Business WireConference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ:MASI) will release first quarter 2025 financial results for the period ended March 29, 2025, after the market closes on Tuesday, May 6,
- 1y agoMASIApple Inc. vs Masimo Corporation - AIA Trial, DismissedUS Patent Trial and Appeal Board
- 1y agoMASIApple Inc. vs Masimo Corporation - AIA Trial, DismissedUS Patent Trial and Appeal Board
- 1y agoMASIMASIMO CORPORATION - Appeal, AffirmedUS Patent Trial and Appeal Board
- 1y agoMASIMasimo to Present in the 24th Annual Needham Virtual Healthcare ConferenceBusiness WireMasimo (NASDAQ:MASI) today announced that its management will participate in the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025 at 2:15 p.m. Eastern time. A live webcast of the
- 1y agoDXCMMASIPFEDexcom Appoints Jon Coleman as Chief Commercial OfficerBusiness WireDexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Jon Coleman as chief commercial officer. In this role, Mr. Coleman will assume responsibility for Dexcom's global
- 1y agoMASIMasimo to Present in the 46th Annual Raymond James Institutional Investor ConferenceBusiness WireMasimo (NASDAQ:MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A live webcast of the
- 1y agoMASIApple Inc. vs Masimo Corporation - AIA Trial, DismissedUS Patent Trial and Appeal Board
- 1y agoMASIApple Inc. vs Masimo Corporation - AIA Trial, DismissedUS Patent Trial and Appeal Board
- 1y agoMASIMasimo Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Updated Full-Year 2025 GuidanceBusiness WireMasimo (NASDAQ:MASI) today announced its financial results for the fourth quarter and full-year ended December 28, 2024 and provided updated estimates for its full-year 2025 guidance. Fourth Quarter 2024 Financial
- 1y agoMASINARIOMMasimo Announces Leadership TransitionBusiness WireKatie Szyman Appointed Chief Executive Officer and to Board of Directors Interim CEO Michelle Brennan Named Chairman of Masimo's Board Today the Board of Directors (the "Board") of Masimo (NASDAQ:MASI), a leading
- 1y agoMASIMasimo Announces Select Preliminary 2024 Financial Results and 2025 GuidanceBusiness WireComplete fourth quarter and full-year 2024 financial results will be announced on Tuesday, February 25, 2025 Masimo Corporation (NASDAQ:MASI) today announced select preliminary financial results for the fourth quarter
- 1y agoMASIMasimo to Present in the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness WireMasimo (NASDAQ:MASI) today announced that its management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 a.m. Pacific time. A live webcast of the presentation
- 1y agoMASIMasimo to Present in the Piper Sandler 36th Annual Healthcare ConferenceBusiness WireMasimo (NASDAQ:MASI) today announced that its management will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 8:30 a.m. Eastern time. A live webcast of the presentation
- 1y agoMASIMasimo to Present in the Jefferies London Healthcare ConferenceBusiness WireMasimo (NASDAQ:MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:30 a.m. GMT. A live webcast of the presentation will be
- 1y agoMASIMasimo to Present in Stifel 2024 Healthcare ConferenceBusiness WireMasimo (NASDAQ:MASI) today announced that its management will participate in the Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 11:30 a.m. Eastern Time. A live webcast of the presentation will be
- 2y agoMASIMasimo Corporation (MASI) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoMASIMasimo Reports Third Quarter 2024 Financial ResultsBusiness WireThird Quarter 2024 Highlights: Healthcare revenue of $343.3 million increased 11.5% on a reported basis and 11.7% on a constant currency basis(1); GAAP net income per diluted share was $0.18; and Non-GAAP(1) net
- 2y agoMASIVanderbilt University Medical Center Integrates Masimo Radius VSM™ in Proactive Care Protocol to Combat Emergency Room CongestionBusiness WireRenowned Healthcare Facility Launches Advanced Wireless Monitoring Technology in the Emergency Department, Reducing Wait Times and Improving Patient Prioritization Masimo (NASDAQ:MASI) today announced that Vanderbilt